4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-020273
President and CEO sold 19,421 shares at an average $11.58 ($224,992)
- President and CEO acquired 43,028 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KANE MATTHEW R. · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-10 | Exercise or conversion : show line 1 in the form | +21,514 | $0.04 | $861 | 1,915,573 | D |
| 2021-03-10 | Sale : show line 2 in the form | −9,710 | $11.79 | $114,481 | 1,905,863 | D |
| 2021-03-11 | Exercise or conversion : show line 3 in the form | +21,514 | $0.04 | $861 | 1,927,377 | D |
| 2021-03-11 | Sale : show line 4 in the form | −9,711 | $11.38 | $110,511 | 1,917,666 | D |
| Open-market sales · 19,421 sh · avg $11.58 · $224,992 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-10 | Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) | −21,514 | 172,112 | D |
| 2021-03-11 | Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) | −21,514 | 150,598 | D |
Loading xslF345X03/doc4.xml…